Piga, A., Galanello, R., Forni, G., Cappellini, M., Origa, R., Zappu, A., Donato, G., Bordone, E., Lavagetto, A., Zanaboni, L., Sechaud, R., Hewson, N., Ford, J., Opitz, H. and Alberti, D. (2006) “Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload”, Haematologica. Pavia, Italy, 91(7), pp. 873-880. Available at: https://haematologica.org/article/view/4060 (Accessed: 12November2026).